Joycelynne Palmer

3PUBLICATIONS
29CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Feb 14, 2025
Phase 1 trial of durvalumab (anti-PD-L1) combined with lenalidomide in relapsed/refractory cutaneous T-cell lymphoma.

Christiane Querfeld, Joycelynne Palmer, Zhen Han

|Oct 18, 2022
Favorable Activity and Safety Profile of Memory-Enriched CD19-Targeted Chimeric Antigen Receptor T-Cell Therapy in Adults with High-Risk Relapsed/Refractory ALL.

Ibrahim Aldoss, Samer K Khaled, Xiuli Wang

|Nov 19, 2016
Philadelphia chromosome as a recurrent event among therapy-related acute leukemia.

Ibrahim Aldoss, Tracey Stiller, Joo Song

Pageof 1